Reasons for compliance or noncompliance with advice to test for hepatitis C via an internetmediated blood screening service: a qualitative study

Zuure, Freke R.; Heijman, Titia; Urbanus, Anouk T.; Prins, Maria; Kok, Gerjo; Davidovich, Udi
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p293
Academic Journal
Background: Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCV-infected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for compliance and noncompliance with advice to test for HCV via the online blood testing service. Methods: Semistructured telephone interviews were conducted with 33 website visitors who had been advised to test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using psychosocial theories of health behavior. Results: Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not specific to the online service were: knowing one's status can prevent liver disease and further transmission of HCV, HCV is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one's social environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive test result, avoiding threatening information, and a discouraging social environment. Conclusions: Features specific to the online service played a significant role in motivation to test for HCV above and beyond the more conventional perceived health benefits of HCV testing. However, some online specific features were considered problematic and need to be adapted. Methods and strategies for dealing with these impeding factors and for improving compliance with testing via the online service are outlined.


Related Articles

  • Global control of hepatitis C: where challenge meets opportunity. Thomas, David L // Nature Medicine;Jul2013, Vol. 19 Issue 7, p850 

    We are entering an important new chapter in the story of hepatitis C virus (HCV) infection. There are clear challenges and opportunities. On the one hand, new HCV infections are still occurring, and an estimated 185 million people are or have previously been infected worldwide. Most HCV-infected...

  • Hepatitis C Virus Prevention, Care, and Treatment: From Policy to Practice. Ward, John W.; Valdiserri, Ron O.; Koh, Howard K. // Clinical Infectious Diseases;Jul2012 Supplement 1, Vol. 55 Issue suppl_1, pS58 

    The prevention of hepatitis C virus (HCV) infection and associated health conditions (eg, cirrhosis and hepatocellular carcinoma) is a public health priority in the United States. Hepatitis C virus–related morbidity and mortality is increasing at a time when the advent of highly effective...

  • Modelling the past, current and future HCV burden in France: detailed analysis and perspectives. Deuffic-Burban, Sylvie; Mathurin, Philippe; Valleron, Alain-Jacques // Statistical Methods in Medical Research;Jun2009, Vol. 18 Issue 3, p233 

    Two national HCV projections have been published in France which assumed that a part of observed hepatocellular carcinoma (HCC) deaths is a consequence of HCV epidemic. They applied the back-calculation method, in combination with a Markov model, to reconstruct the past history of HCV infection...

  • HCV protein causes cancer.  // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p943 

    Discusses findings of Japanese researchers that the hepatitis C virus (HVC) core protein induces hepatocellular carcinoma. Development of hepatic steatosis in laboratory mice as histologic feature of chronic hepatitis C; Characteristics of mice carrying HCV envelope genes.

  • Incomplete response of interferon treatment has an important role for the prevention of hepatocellular carcinoma. Hayashi, Norio // Journal of Gastroenterology;1999, Vol. 34 Issue 5, p655 

    Editorial. Focuses on the incidence of hepatocellular carcinoma (HCC) in Japan. Incidence rate of HCC in cirrhotic patients with antibodies to hepatitis C virus (HCV); Treatment of HCV.

  • Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. Fujita, Naoki; Takei, Yoshiyuki // Journal of Gastroenterology;Nov2007, Vol. 42 Issue 11, p923 

    The article discusses various reports publishes within the issue, including one on chronic hepatitis C virus and another on iron reduction.

  • All-out war against hepatitis C.  // Science Illustrated;Jul/Aug2012, Vol. 5 Issue 4, p42 

    The article focuses on the hepatitis C virus (HCV) that can cause severe diseases including cirrhosis of the liver and liver cancer and drugs than can effectively fight HCV that has potential to cause a global health disaster. According to the World Health Organization (WHO), up to 170 million...

  • Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. Paranaguá-Vezozzo, Denise C.; Ono, Suzane K.; Alvarado-Mora, Mónica V.; Farias, Alberto Q.; Cunha-Silva, Marlone; França, João I. D.; Alves, Venancio A. F.; Sherman, Morris; Carrilho, Flair José // Annals of Hepatology: Official Journal of the Mexican Associatio;Jul/Aug2014, Vol. 13 Issue 4, p386 

    Background and aim. The lack of information about hepatocellular carcinoma (HCC) in Brazil weakens health policy in preventing deaths from the illness. The aim of this study was to establish the cumulative incidence and the risk factors for hepatocellular carcinoma development in patients under...

  • Treatment of hepatitis C. The 2002 French consensus. Dhumeaux, D.; marcellin, P.; Lerebours, E. // Gut;Dec2003, Vol. 52 Issue 12, p1784 

    Chronic infection by hepatitis C virus (HCV) affects 170 million people worldwide. In European countries the overall prevalence in adults ranges from 1% to 2%, and more than five million Europeans are thus infected. The high prevalence of HCV infection, together with the risk of severe...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics